Scientists test if new drug copy works the same as the original
NCT ID NCT07008417
Summary
This study aims to see if a new version of the drug cabergoline works the same way in the body as an existing version. It will involve 72 healthy Chinese adults who will take both versions, once on an empty stomach and once after a meal. The main goal is to check if the two drug versions are absorbed equally well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPROLACTINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhejiang Xiaoshan Hospital
Hangzhou, Zhejiang, 200233, China
Conditions
Explore the condition pages connected to this study.